Stamford Therapeutics Consortium — Stamford, Connecticut

Stamford Therapeutics Consortium is a clinical research site located in Stamford, Connecticut, United States.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Stamford Therapeutics Consortium has participated in 68 clinical trials with 13 currently active.

Therapeutic areas: Chronic Idiopathic Constipation, Lyme Disease, SARS-CoV-2.

Sponsors: Ferring Pharmaceuticals, ModernaTX, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stamford Therapeutics Consortium?

Stamford Therapeutics Consortium has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stamford Therapeutics Consortium conducted?

Stamford Therapeutics Consortium has 68 clinical trials on record, with 13 currently active. Their work covers Chronic Idiopathic Constipation, Lyme Disease, SARS-CoV-2.

Is Stamford Therapeutics Consortium accredited by Crixeo Health?

Stamford Therapeutics Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stamford Therapeutics Consortium?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.